CJC-1295 5MG + IPA 5MG - 10MG
CJC-1295 + Ipamorelin is a dual-peptide research blend combining two widely studied compounds in a single formulation. This combination is commonly investigated for its potential interaction with growth hormone-related signaling pathways and broader endocrine system activity.
CJC-1295 is studied for its action on growth hormone-releasing hormone (GHRH) pathways, while Ipamorelin is researched for its selective interaction with ghrelin receptors and related peptide signaling mechanisms. Together, they represent a popular blend in research focused on growth hormone dynamics, receptor activity, and hormonal communication models.
Key Features
Dual-peptide research blend
CJC-1295 5mg + Ipamorelin 5mg
Total peptide content: 10mg
Investigated for growth hormone and endocrine pathways
Research focus on GHRH and ghrelin receptor activity
High purity, research-grade formulation
Lyophilized peptide vial
Specifications
Compound: CJC-1295 + Ipamorelin
Quantity: 10mg total (5mg / 5mg)
Form: Lyophilized powder
Purity: ≥98% (typical)
Storage: 2–8°C (refrigerated)
Stability: Stable under recommended storage conditions
Quality & Assurance
Independently tested for purity and consistency
Manufactured under strict quality standards
Stored and shipped under controlled conditions
Important Notice
This product is intended for laboratory research purposes only.
Not for human consumption or therapeutic use.